Wyndham Wilson, MD, PhD

Internal Medicine, Medical Oncology

National Cancer Institute, National Institutes of Health

BETHESDA, MD

QC-verified· April 2026 PI on 1 trialNPI: 1679863989

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

ALK-negative anaplastic large cell lymphoma

Clinical trials (1)

NCT00082017

Verify independently

ClinicalTrials.gov PI search for Wyndham Wilson
NPPES NPI registry entry

Other specialists for ALK-negative anaplastic large cell lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

Alex F Herrera
City of Hope Medical Center
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
Premal Lulla, MD, M.D
Baylor College of Medicine
TX
Ann (Annie) W Silk
Dana-Farber - Harvard Cancer Center LAO
California
Matthew A Lunning, D.O
University of Nebraska
NE
Won Seog Kim, MD, PhD
Samsung Medical Center
Bistol-Myers Squibb
Bristol-Myers Squibb
Julie Vose, MD, MBA, OTR/L
University of Nebraska
NH

See all specialists for ALK-negative anaplastic large cell lymphoma →

← Back to specialists directory